TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ENGN

enGene Holdings Inc.

Healthcare · Biotechnology

2.00$ +2.1% vs. previous close Closing price · As of: Sep 25, 2026

Investor relations

Report Dates

Investor relations overview for enGene Holdings Inc. (ENGN): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 09/10/2026.

Next report 09/10/2026
Last report 09/08/2026
Earnings surprise by quarter (%)
Q1 24 · 2.1 % 24 Q2 24 · -40.7 % 24 Q3 24 · 8.6 % 24 Q4 24 · 5.6 % 24 Q1 25 · -29.7 % 25 Q2 25 · -6.3 % 25 Q3 25 · -11.8 % 25 Q4 25 · -25.9 % 25 Q1 26 · 23.3 % 26 Q2 26 · 10.4 % 26 Q3 26 · 206.8 % 26

EPS estimate beaten

Full history 6 of 12 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/08/2026 enGene Therapeutics Inc. (ENGN): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?